ERFE and myeloid sarcoma: Furthermore, the potential of myonectin as a lipid regulator in humans may be revealed by extending the analysis to the relationship between myonectin and other indicators that are linked to the pathophysiological mechanisms of MS, such as the FFA profile and the intramuscular lipid content.